The amyloid-inhibiting NCAM-PrP peptide targets Aβ peptide aggregation in membrane-mimetic environments

Sylwia Król, Nicklas Österlund, Faraz Vosough, Jüri Jarvet, Sebastian Wärmländer, Andreas Barth, Leopold L. Ilag, Mazin Magzoub, Astrid Gräslund, Cecilia Mörman

Research output: Contribution to journalArticlepeer-review


Substantial research efforts have gone into elucidating the role of protein misfolding and self-assembly in the onset and progression of Alzheimer's disease (AD). Aggregation of the Amyloid-β (Aβ) peptide into insoluble fibrils is closely associated with AD. Here, we use biophysical techniques to study a peptide-based approach to target Aβ amyloid aggregation. A peptide construct, NCAM-PrP, consists of a largely hydrophobic signal sequence linked to a positively charged hexapeptide. The NCAM-PrP peptide inhibits Aβ amyloid formation by forming aggregates which are unavailable for further amyloid aggregation. In a membrane-mimetic environment, Aβ and NCAM-PrP form specific heterooligomeric complexes, which are of lower aggregation states compared to Aβ homooligomers. The Aβ:NCAM-PrP interaction appears to take place on different aggregation states depending on the absence or presence of a membrane-mimicking environment. These insights can be useful for the development of potential future therapeutic strategies targeting Aβ at several aggregation states.

Original languageEnglish (US)
Article number102852
Issue number8
StatePublished - Aug 20 2021


  • biophysics
  • molecular neuroscience
  • structural biology

ASJC Scopus subject areas

  • General


Dive into the research topics of 'The amyloid-inhibiting NCAM-PrP peptide targets Aβ peptide aggregation in membrane-mimetic environments'. Together they form a unique fingerprint.

Cite this